Section Arrow
Quote
UTHR.NASDAQ
- United Therapeutics Corp
Quotes are at least 15-min delayed:2025/01/11 17:18 EST
Last
 364.97
-1.64 (-0.45%)
Day High 
365.33 
Prev. Close
366.61 
1-M High
383 
Volume 
264.86K 
Bid
355.91
Ask
365.14
Day Low
358.795 
Open
362.94 
1-M Low
350.6 
Market Cap 
16.37B 
Currency USD 
P/E 16.11 
%Yield -- 
10-SMA 359.63 
20-SMA 361.88 
50-SMA 370.27 
52-W High 417.815 
52-W Low 208.6249 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
22.76/34.90
Enterprise Value
16.67B
Balance Sheet
Book Value Per Share
136.66
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
53.80K
Operating Revenue Per Share
49.37
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CDTConduit Pharmaceuticals0.1233+0.0413+50.37%-- 
MRSNMersana Therapeutics0.72-0.58-44.62%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.2787+0.0227+8.87%-- 
ZVSAZyVersa Therapeutics1.47+0.29+24.58%0PE
SANASana Biotechnology3.66-0.64-14.88%-- 
Quotes are at least 15-min delayed：2025/01/11 17:18 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus onthe prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.